Oxaluria Clinical Trials in Boston, Massachusetts
2 recruitingBoston, Massachusetts
Showing 1–2 of 2 trials
Recruiting
Phase 2
Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD
End Stage Renal DiseasePrimary Hyperoxaluria Type 1
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company28 enrolled18 locationsNCT04580420
Recruiting
Prospective Research Rare Kidney Stones (ProRKS)
Adenine Phosphoribosyltransferase DeficiencyCystinuriaDent Disease+2 more
Mayo Clinic220 enrolled11 locationsNCT02780297